We are committed to joining other healthcare stakeholders, government entities, civic organizations, law enforcement agencies and individuals to overcome this terrible tragedy.
Here's how:
Read our opinion pieces in the following publications:
Community Outreach
The
AmerisourceBergen Foundation remains committed to providing communities with
the resources needed to help prevent opioid misuse. We continue to
evaluate how we can best leverage our unique resources to support initiatives
or organizations that aim to address the nation’s opioid epidemic.
The AmerisourceBergen Foundation Safe Disposal Support Program
The Safe Disposal Support Program provides organizations with access to drug deactivation pouches or packets that enable community members to dispose of unused or expired prescription drugs in a safe manner. The deactivation resources allow for local, on-site disposal and can be distributed to other organizations, individuals or households.
Ensuring Safe and Secure Drug Distribution
AmerisourceBergen does not prescribe drugs, provide them directly to patients or
take any action to drive demand for them. We transport medicine from
manufacturers to licensed pharmacies, hospitals and other dispensaries.
Ensuring the safety and security of this process has always
been paramount. To achieve this, we continuously evaluate, enhance, strengthen
and expand the proven measures we have implemented to maintain the integrity of
every order we ship. These processes include:
Due diligence
Order monitoring
Daily reporting
Licensing
-
Take no action whatsoever to promote prescribing or otherwise increase demand for opioids.
-
Do not offer our sales representatives special compensation or incentives of any kind that target opioid orders.
-
Continuously monitor all orders and immediately flag those deemed potentially suspicious.
Perspective from our CEO
The Surprising Morality of Opioid Distribution
STEVEN H. COLLIS, CHAIRMAN, PRESIDENT AND CEO, AMERISOURCEBERGEN
Advocating for the Highest Regulatory Standards
Opioids are heavily regulated by the government; from the
time they are produced to the time they are dispensed to patients. Every
stakeholder in this process — the manufacturer, distributor, prescriber and dispenser
— must strictly adhere to requirements outlined in the Federal Code of
Regulations.
AmerisourceBergen enthusiastically endorses these
guidelines and strongly advocates for the implementation of additional
measures.
ARTICLE: INSIDE SOURCES
Sound Policy and More Transparency Can Help Companies Fight the Opioid Crisis
STEVEN H. COLLIS, PRESIDENT, CHAIRMAN AND CEO, AMERISOURCEBERGEN